| Dec 18 2024 |
AI in Drug Discovery: 2025 Outlook |
Foley & Lardner LLP |
| Dec 18 2024 |
Three Overhauls to Accelerated Drug Approval You Need to Know About: Novel Endpoints, Confirmatory Trials, and Expedited Withdrawal of Approvals |
ArentFox Schiff LLP |
| Dec 18 2024 |
Third Circuit Rules New Jersey Marijuana Law Lacks Private Right of Action to Enforce Employment Protections |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Dec 17 2024 |
Preparation for 2024 Fiscal Year-End SEC Filings and 2025 Annual Shareholder Meetings |
Mintz |
| Dec 17 2024 |
EPA Updates Recommendations of Specifications, Standards and Ecolabels for Federal Purchasing |
Bergeson & Campbell, P.C. |
| Dec 17 2024 |
Private Equity: Senators Markey and Braun Seek Information on Role in Treatment for Opioid Use Disorder |
Foley & Lardner LLP |
| Dec 17 2024 |
FDA Updates Guidance on Premarket Engagement for Genome-Edited Plant Varieties |
Keller and Heckman LLP |
| Dec 17 2024 |
Drunk Driving Laws: Penalties and Legal Consequences for Offenders |
Buckfire Law |
| Dec 17 2024 |
Unpacking Averages: Exploring Data on FDA’s Breakthrough Device Program Obtained Through FOIA |
Epstein Becker & Green, P.C. |
| Dec 17 2024 |
Drug Test Woes: State Law Protections for Employee Cannabis Use May Not Protect Them After All |
Bradley Arant Boult Cummings LLP |
| Dec 16 2024 |
EPA Issues Final SNURs for Multi-Walled Carbon Nanotubes (Generic) (P-21-216 and P-21-217) |
Bergeson & Campbell, P.C. |
| Dec 16 2024 |
Key Takeaways: HHS and DOJ’s Health Care Fraud and Abuse Control Program Report |
Robinson & Cole LLP |
| Dec 16 2024 |
LDT Final Rule Series: Part 3 – Legal Challenges |
Sheppard, Mullin, Richter & Hampton LLP |
| Dec 16 2024 |
CODEX ALIMENTARIUS: Main Outcome of the 48th Committee on Food Labelling (CCFL48) |
Keller and Heckman LLP |
| Dec 16 2024 |
Key Proposals from the CY 2026 Medicare Advantage and Part D Proposed Rule |
Sheppard, Mullin, Richter & Hampton LLP |
| Dec 16 2024 |
A Quick Take on FDA’s New Draft Accelerated Approval Guidance for Drug Products |
Keller and Heckman LLP |
| Dec 16 2024 |
A Holiday Surprise for U.S. Distilleries: TTB Unveils Long-Awaited ‘American Single Malt’ Standard of Identity |
Norris McLaughlin P.A. |
| Dec 16 2024 |
Behavioral Health Law Ledger | December 2024 |
Greenberg Traurig, LLP |
| Dec 16 2024 |
China Proposes Amendments to Imported Pet Food Regulation |
Keller and Heckman LLP |
| Dec 13 2024 |
Proposition 65: OEHHA Adopts Changes to “Short-Form” Warning Option |
Bergeson & Campbell, P.C. |
| Dec 13 2024 |
OPPT Deputy Director Mark Hartman Will Become Director of FDA’s Office of Food Chemical Safety, Dietary Supplements, and Innovation |
Bergeson & Campbell, P.C. |
| Dec 13 2024 |
The Shifting Landscape of Marijuana Research in the US |
Womble Bond Dickinson (US) LLP |
| Dec 13 2024 |
Florida Telemarketer Sentenced to 15 Years in Prison for $67 Million Medicare Fraud Scheme |
ArentFox Schiff LLP |
| Dec 13 2024 |
FDA Issues New Guidance on Cosmetic Product Registration and Listing |
Keller and Heckman LLP |
| Dec 13 2024 |
Massachusetts Issues Additional Update to Non-Resident Pharmacy Rules |
Polsinelli PC |
| Dec 12 2024 |
FDA Issues Letter re Lead in Certain Imported Cookware |
Keller and Heckman LLP |
| Dec 12 2024 |
EPA Begins Public Consultation on Interim Framework for Advancing Consideration of Cumulative Impacts |
Bergeson & Campbell, P.C. |
| Dec 12 2024 |
Newsflash: What the New Proposition 65 Short-Form Warnings Mean for Consumer Products Companies |
ArentFox Schiff LLP |
| Dec 12 2024 |
GoodRx Agrees to Pay $25 Million Settlement for Privacy Violations |
Hunton Andrews Kurth |
| Dec 12 2024 |
Trending in Telehealth: November 19 – 25, 2024 |
McDermott Will & Schulte LLP |
| Dec 11 2024 |
Massachusetts Implements Long-Awaited Licensing Regime for Out-of-State Pharmacies |
McDermott Will & Schulte LLP |
| Dec 11 2024 |
Lawsuit Alleges Intentional Sale of “Harmful and Addictive” Ultra-Processed Foods |
Keller and Heckman LLP |
| Dec 11 2024 |
This Week in 340B: December 3 – 9, 2024 |
McDermott Will & Schulte LLP |
| Dec 11 2024 |
EPA Announces Proposed Rule to Revoke Most Food Uses of the Insecticide Chlorpyrifos |
Bergeson & Campbell, P.C. |
| Dec 11 2024 |
Antibody Drug Conjugates Keep Growing: What You Need to Know |
Foley & Lardner LLP |
